Barclays
LVAC

Barclays’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Barclays’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-600
Closed -$6.26K – 5309
2023
Q1 		$6.26K Hold
600
– – ﹤0.01% 4795
2022
Q4 		$6.11K Hold
600
– – ﹤0.01% 4979
2022
Q3 		$6K Buy
+600
New +$6.01K ﹤0.01% 4485

Barclays's LVAC Position: Q2 2023 in Review

Barclays sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 600 shares — an estimated $6.26K sold.

Barclays first reported a position in LVAC in Q3 2022 and held it in 3 quarters. The position peaked at $6.26K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

  • Barclays reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Barclays sold 600 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $6.26K.
  • Barclays first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • Barclays's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $6.26K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.